|
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC? |
|
|
|
Title: |
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC? |
Author: |
Ginzac, Angeline Thivat, Emilie Petorin, Caroline Richard, Damien Herviou, Pauline Molnar, Ioana Devaud, Hervé Creveaux, Isabelle Ferrer, Florent Authier, Nicolas Jary, Marine Pezet, Denis Durando, Xavier |
Appeared in: |
Cancer, chemotherapy and pharmacology |
Paging: |
Volume 93 () nr. 3 pages 225-236 |
Year: |
2023-11-07 |
Contents: |
|
Publisher: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|